Trial Profile
Doubleblind, Randomised, Single Centre Investigator Sponsored Study of Applications Site Reactions After Deep and Superficial Subcutaneous and Intradermal Injection of Insulin Detemir and Saline in Subjects With Diabetes Mellitus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Insulin detemir (Primary) ; Insulin detemir (Primary)
- Indications Diabetes mellitus
- Focus Adverse reactions
- Acronyms APPLY
- 30 Jul 2010 Actual end date (Jul 2010) added as reported by ClinicalTrials.gov.
- 30 Jul 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 12 Mar 2008 New trial record.